Haiti ’s Healthcare Nears Collapse Amid Violence as Hospitals Shutter, Medicine Dwindles
PORT-AU-PRINCE, Haiti — On a recent morning at a hospital in the heart of gang territory in Haiti’s capital, a woman began convulsing before her body went limp as a doctor and two nurses raced to save her.
[time-brightcove not-tgx=”true”]
They stuck electrodes to her chest and flipped on an oxygen machine while keeping their eyes on a computer screen that reflected a dangerously low oxygen level of 84%.
No one knew what was wrong with her.
Even more worrisome, the Doctors Without Borders hospital in the Cite Soleil slum was running low on key medicine to treat convulsions.
“The me...
Source: TIME: Health - April 23, 2024 Category: Consumer Health News Authors: Dánica Coto / AP Tags: Uncategorized News Desk overnight wire Source Type: news
A case of anaphylactic shock due to levofloxacin eye drops confirmed by a prick test - Ikeda I, Fukushima S.
We report a case of anaphylactic shock caused by levofloxacin eye drops during the treatment of a corneal injury, confirmed by a prick test. Reported cases of... (Source: SafetyLit)
Source: SafetyLit - March 15, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Food Allergy Highlights From AAAAI 2024 Food Allergy Highlights From AAAAI 2024
Food allergy highlights from AAAAI 2024 include strong results for omalizumab against multiple food allergens and comparable efficacy for intranasal epinephrine vs injectable anaphylaxis therapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 14, 2024 Category: Consumer Health News Tags: None ReCAP Source Type: news
Food Allergies in College 101: Tips to Cope
THURSDAY, March 7, 2024 -- Food allergies are difficult to manage at any age, but college students face complex challenges when it comes to navigating the dangers posed by the possibility of life-threatening anaphylaxis. A recent review published... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 7, 2024 Category: General Medicine Source Type: news
AAAAI: Nasal Delivery of Epinephrine Safe, Effective for Anaphylaxis
WEDNESDAY, March 6, 2024 -- Nasal powder formulations of epinephrine are effective and show superior stability to EpiPens, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma& Immunology, held from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 6, 2024 Category: Pharmaceuticals Source Type: news
Doctor's Family Sues Disney Over Food Allergy Death; Doctor Skipped Payroll Taxes?
(MedPage Today) -- The family of New York doctor Kanokporn Tangsuan, DO, is suing Disney following her death, allegedly from eating a meal that wasn't allergen-free. Tangsuan was highly allergic to nuts and dairy and reportedly died from anaphylaxis... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 29, 2024 Category: American Health Source Type: news
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Investor Update - February 25, 2024 Category: Pharmaceuticals Source Type: news
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Media News - February 25, 2024 Category: Pharmaceuticals Source Type: news
Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2024 Category: Pharmaceuticals Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news
Study Shows Nasal Powder Epinephrine Provides Superior Stability to EpiPens
Needle-free, nasal delivery of epinephrine has been shown to be an effective and stable treatment for anaphylaxis. MILWAUKEE, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Nasal powder formulations of epinephrine demonstrated superior stability and comparable plasma exposure to EpiPens according to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 12, 2024 Category: Pharmaceuticals Tags: SVY TRI FVT Source Type: news
Death of a child due to venom toxicity following multiple honey bee stings: a case report - Singh BK, Sharma M, Lra SP, Chauhan M.
Most bee stings are not life-threatening. Bee venom often causes local, mild allergic reactions in people, but even a single bee sting may induce a fatal anaphylactic reaction. Usually, anaphylactic reaction is the cause of death, but, when a child suffers... (Source: SafetyLit)
Source: SafetyLit - February 12, 2024 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Acid-Suppressive Medication and Antimicrobial Use in Infancy Associated with Food Allergy and Anaphylaxis
New research shows infants exposed to acid-suppressive medication had nearly a 6-fold increased risk of food allergy MILWAUKEE, Feb. 6, 2024 /PRNewswire-PRWeb/ -- Patients who were prescribed proton pump inhibitors (PPIs) in infancy demonstrated increased food allergy risk, according to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 6, 2024 Category: Pharmaceuticals Tags: SVY TRI Source Type: news
Clinical Challenges: Anaphylaxis and Epinephrine
(MedPage Today) -- Approximately 2% of adults and 4% to 8% of children have food allergies in the U.S., with food-induced anaphylaxis resulting in roughly 30,000 emergency department visits, 2,000 hospitalizations, and 150 deaths each year.
While... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - January 31, 2024 Category: Allergy & Immunology Source Type: news
